Life Sciences Commercial Disputes

Product development in the life sciences sector is frequently complex, costly, and time-consuming, and collaborations between companies are common. Disputes may arise at all stages of development and commercialization. Our experience helps clients navigate disputes involving drug development and commercialization and identify relevant commercial factors (size of the opportunity, therapeutic area, business risks, etc.). CRA has provided expert reports and testimony evaluating development and commercialization efforts and assessing damages associated with alleged contractual breaches.


  • 01
    CRA addressed a claim that a company had improperly failed to pay required development milestones upon termination of a drug development program
    In litigation before the Delaware Court of Chancery, a CRA expert was asked to address the basis for a company’s decision to terminate the development of a...
    View engagement
  • 02
    AAA arbitration regarding a collaboration and license agreement
    CRA provided expert reports and testimony on behalf of the respondent in an AAA arbitration concerning the “fair market value” of rights exchanged in later...
    View engagement
  • 03
    AAA arbitration regarding breach of purchase agreement
    CRA was retained by the claimant in a dispute at AAA alleging breach of a purchase agreement due to the respondent’s alleged failure to make contracted minimum...
    View engagement

Subscribe to recieve our latest Insights.